165 related articles for article (PubMed ID: 16777978)
1. C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts.
Strle K; Broussard SR; McCusker RH; Shen WH; LeCleir JM; Johnson RW; Freund GG; Dantzer R; Kelley KW
Endocrinology; 2006 Sep; 147(9):4363-73. PubMed ID: 16777978
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.
Strle K; Broussard SR; McCusker RH; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
Endocrinology; 2004 Oct; 145(10):4592-602. PubMed ID: 15256490
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts.
Broussard SR; McCusker RH; Novakofski JE; Strle K; Shen WH; Johnson RW; Freund GG; Dantzer R; Kelley KW
Endocrinology; 2003 Jul; 144(7):2988-96. PubMed ID: 12810554
[TBL] [Abstract][Full Text] [Related]
4. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
6. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
Krause D; Lyons A; Fennelly C; O'Connor R
J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
[TBL] [Abstract][Full Text] [Related]
8. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent.
MacRae VE; Burdon T; Ahmed SF; Farquharson C
J Endocrinol; 2006 Nov; 191(2):369-77. PubMed ID: 17088406
[TBL] [Abstract][Full Text] [Related]
9. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
Sharfi H; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
[TBL] [Abstract][Full Text] [Related]
10. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells.
Mingo-Sion AM; Ferguson HA; Koller E; Reyland ME; Van Den Berg CL
Breast Cancer Res Treat; 2005 Jun; 91(3):259-69. PubMed ID: 15952059
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
Layne MD; Farmer SR
Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
[TBL] [Abstract][Full Text] [Related]
12. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937.
Ragg SJ; Kaga S; Berg KA; Ochi A
J Immunol; 1998 Aug; 161(3):1390-8. PubMed ID: 9686602
[TBL] [Abstract][Full Text] [Related]
13. IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts.
Broussard SR; McCusker RH; Novakofski JE; Strle K; Shen WH; Johnson RW; Dantzer R; Kelley KW
J Immunol; 2004 Jun; 172(12):7713-20. PubMed ID: 15187154
[TBL] [Abstract][Full Text] [Related]
14. MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2-vitamin D3 in the C2C12 muscle cell line.
Buitrago CG; Ronda AC; de Boland AR; Boland R
J Cell Biochem; 2006 Mar; 97(4):698-708. PubMed ID: 16215981
[TBL] [Abstract][Full Text] [Related]
15. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.
Stewart CE; Newcomb PV; Savage PB; Dickens M; Tavare J; Holly JM
Growth Horm IGF Res; 1999 Apr; 9(2):131-42. PubMed ID: 10373346
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
18. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307).
Aguirre V; Uchida T; Yenush L; Davis R; White MF
J Biol Chem; 2000 Mar; 275(12):9047-54. PubMed ID: 10722755
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation.
Sarbassov DD; Peterson CA
Mol Endocrinol; 1998 Dec; 12(12):1870-8. PubMed ID: 9849961
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
